Sagimet Biosciences Inc.
- Stock
- Ticker SGMT
- ISIN US7867001049
- Nasdaq
Performance, volatility and drawdowns of Sagimet Biosciences Inc. since 07/2023, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $23,770. Global equities (VT): $15,235.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −89.7% in 04/2025, measured from the peak in 01/2024. The old peak has not been reached again yet.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 12/2024 | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 03/2026 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Operating income | -18 | -20 | -12 | -14 | -11 | -12 | -16 | -22 |
| Net income | -16 | -18 | -10 | -13 | -9.6 | -11 | -14 | -19 |
| Earnings per share | -0.50 | -0.56 | -0.32 | -0.40 | -0.30 | -0.33 | -0.26 | -0.31 |
| Balance sheet | ||||||||
| Total assets | 160 | 146 | 137 | 128 | 116 | 108 | 263 | 282 |
| Liabilities | 4.5 | 7.2 | 7.2 | 9.1 | 5.1 | 5.3 | 7.3 | 40 |
| Equity | 156 | 139 | 130 | 119 | 111 | 102 | 256 | 242 |
| Cash | 76 | 65 | 42 | 32 | 35 | 37 | 166 | 111 |
| Cash flow | ||||||||
| Operating cash flow | -11 | -15 | -9.1 | -10 | -12 | -8.6 | -11 | -12 |
| Free cash flow | -11 | -15 | -9.1 | -10 | -12 | -8.6 | -11 | -12 |
Value it:DCF calculatorMultiples calculator
Annual returns
Best year 2025 at +31.6%, weakest 2024 at −17.0%. 1 of 2 full years were positive. * partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 12 Nov 2026 | −$0.31 |
| 11 Aug 2026 | −$0.26 |
| 12 May 2026 | −$0.33 |
| 11 Mar 2026 | −$0.30 |
| 13 Nov 2025 | −$0.40 |
| 13 Aug 2025 | −$0.32 |
| 8 May 2025 | −$0.56 |
| 12 Mar 2025 | −$0.50 |
| 14 Nov 2024 | −$0.45 |
| 14 Aug 2024 | −$0.25 |
| 15 May 2024 | −$0.23 |
| 25 Mar 2024 | −$39.07 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €513m
- Market cap in trading currency
- $566m
- Enterprise value
- $330m
- P/E
- –
- P/S
- –
- P/B
- 2.34
- EV/Sales
- –
- EV/EBITDA
- –
- Earnings yield
- –
- FCF yield
- -7.7%
Results (last four quarters)
- Revenue
- –
- Gross profit
- –
- EBITDA
- –
- Net income
- −$53.3m
- Earnings per share
- −$1.20
- Revenue per share
- –
- Revenue growth
- –
- Earnings growth
- –
Profitability
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity
- -29.5%
- Return on assets
- -18.9%
Balance sheet and cash flow
- Cash
- $236m
- Cash per share
- $3.79
- Financial debt
- –
- Debt/equity %
- –
- Current ratio
- 6.34
- Book value per share
- $3.88
- Operating cash flow
- −$43.7m
- Free cash flow
- −$43.7m
Dividend
- Dividend yield
- 0.00%
- Dividend (12 months)
- $0.00
- Yield (12 months)
- 0.00%
- Payout ratio
- –
- Ex-dividend date
- –
Shares and trading
- Shares outstanding
- 62.3m
- Volume
- 1.50m
- Avg. volume 3 months
- 1.24m
- Relative volume
- 1.2
Price and technicals
- Price
- $9.08
- 1 day
- −5.6%
- 52-week high
- $11.41
- 52-week low
- $4.55
- Distance to 52-week high
- −20.4%
- Distance to 52-week low
- +99.6%
- Distance to 50-day line
- −7.0%
- Distance to 200-day line
- +16.4%
- RSI (14)
- 42
- Volatility 1M
- 81.8%
Performance
- 1 week
- −11.2%
- 1 month
- −8.7%
- 3 months
- −11.1%
- 6 months
- +28.1%
- YTD
- +53.4%
- 1 year
- +15.7%
Dates
- Fiscal year end
- 31 Dec 2025
- Most recent quarter
- 30 Sep 2026
Frequently asked questions
How has SGMT performed since 07/2023?
$10,000 grew to $5,693 by 20 Nov 2026, which is −15.5% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is SGMT?
Volatility was 117.6% per year, measured on monthly returns. The largest decline from a peak was −89.7%, with the low in 04/2025.
How does SGMT compare with a broad equity ETF?
Over the same period Global equities (VT) returned +13.4% per year at 13.1% volatility, SGMT returned −15.5% at 117.6%. The correlation of monthly returns was 0.33; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.